Improvement of fatigue in generalised myasthenia gravis with zilucoplan

ConclusionTreatment with zilucoplan demonstrated statistical and clinically meaningful improvements in fatigue scores and severity versus placebo during RAISE, which were sustained to Week 60 in RAISE-XT.
Source: Journal of Neurology - Category: Neurology Source Type: research